Skip to main content

COVID-19 and Related Funding Opportunities

Agency Responses to COVID-19 and Additional Resources

The National Science Foundation has issued Important Notice No 146 to the Community Regarding COVID-19. NSF has also issued additional guidance on NSF’s implementation of the Office of Management and Budget (OMB) Memorandum (M-20-17), entitled, Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations. NSF has implemented flexibilities authorized by OMB from specific administrative, financial management and audit requirements contained in 2 CFR Part 200, Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards without compromising accountability requirements. Any questions about the policies described in the NSF Guidance should be directed to Questions specific to a particular award should be directed to the cognizant NSF Program Officer. NSF is working to update existing FAQs and other resources to reflect NSF’s new guidance and will keep you informed on our website at:

As you can imagine, NIH is devoting significant resources to COVID-19. In addition to dedicating regularly appropriated funds, to date NIH has received emergency funding for COVID-19-related activities in two supplemental bills (available from the NIH Office of Budget website), that together provide:

  • $1.532 billion for NIAID
  • $103.4 million for NHLBI
  • $60 million for NIBIB
  • $36 million for NCATS
  • $30 million for the NIH Office of Director
  • $10 million for NIEHS
  • $10 million for NLM

To get funding as quickly as possible to the research community, we are using Urgent and Emergency competing revisions and administrative supplements to existing grant awards.  This approach allows us to leverage resident expertise, getting additional funding to those researchers who are already working with other organisms, models, or tools so that they can quickly shift focus to the novel coronavirus. These Urgent and Emergency competitive revision Funding Opportunity Announcements (FOAs) allow NIH to fund applications quickly, often in under three months, sometimes much quicker than that, because evaluation for scientific and technical merit is done by an internal review panel convened by staff of the NIH awarding institute or center rather than by our traditional peer review process.

Council on Governmental Relations (COGR) has compiled a listing of Institutional and Agency Responses to COVID-19 and Additional Resources.  The listing will be updated as Agencies and Universities provide additional information and includes links provided by Universities to COVID-19 updated institutional travel policies, a helpful one-stop resource.

For updated information on the federal response, including news releases, fact sheets, rumor control, best practices and FAQ’s please visit the FEMA Coronavirus website.


GrantForward Funding Opportunities for COVID-19

As the COVID-19 situation continues to develop, it’s critically important that researchers, who are learning about the virus and pursuing science-based solutions to the global coronavirus pandemic, can find the funding they need. With this in mind, GrantForward is proud to provide free access to a list of funding opportunities in the area of COVID-19 here:

Funding Opportunities Searches through INFOED’s SPIN

We are tracking COVID-19/Coronavirus-related funding opportunities and other types of community resources and making that information available to everyone. Accessing this information does not require a subscription or any kind of registration with InfoEd Global.

Other Funding Opportunities

National Institutes of Health (NIH)NIAIDAdministrative SupplementNot limited2/6/2020 (applications accepted through 2/6/2021)
National Institutes of Health (NIH)NIAID,NIGMSNotice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)Not limited2/6/2020 (applications accepted through 4/8/2020)
National Institutes of Health (NIH)NIGMSNotice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2Must reflect your needs3/5/2020 (applications accepted through 2/5/2021)
National Institutes of Health (NIH)NHLBINotice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)Not limited3/17/2020 (applications accepted through 10/5/2020)
Department of Energy (DOE)Invitation for COVID-19 scientific questionsDOE Resources3/18/2020 (reviews start 3/18 but accepted on a rolling basis)
National Institutes of Health (NIH)NIDANotice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus$100K direct costs/yr3/19/2020 (applications accepted through 3/31/2021)
Department of Defense(DoD)Request for Information for PPE in response to COVID-19N/A3/24/2020 (information accepted on a rolling basis)
National Institutes of Health (NIH)NIAIDNotice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)Must reflect your needs3/25/2020 (applications accepted through 3/25/2021)
Massachusetts Institute of Technology (MIT)TPrize ChallengeUp to $100,000 available3/31/2020
Alliance for a Healthier World (AHW)COVID-19 Launchpad Grant$25,0004/5/2020
National Institutes of Health (NIH)NCATSCheck RFA(s) within4/5/2020 (application deadlines through 4/5/2021)
American Heart Association (AHA)Rapid Response Grant COVID-19 and Its Cardiovascular Impact$100,000 (plus $150,000 for Coordinating Center)4/6/2020
LifeArc (UK) LifeArc COVID-19 Fund for the development and testing of therapeutics£10M4/6/2020 (LOI)
Department of Defense (DoD)Prototype Development to Combat Novel Coronavirus Disease COVID-19TBD4/15/2020
Centers for Disease Control (CDC)Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health$3,000,0004/20/2020
Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)Negotiated after white paper stage10/31/2021 (full application)
JHU School of Public Health Center for Alternatives to Animal Testing Fast-track grant for research on non-animal approaches to investigate mechanisms, medicines, and vaccines for coronaviruses$40,0004/30/2020
National Institutes of Health (NIH)NCATSNotice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath NeedMust reflect your needs5/4/2020 (other FOA deadlines within)
National Institutes of Health (NIH)NIAID,NIAInvestigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)Not limited5/13/2020; 9/13/2020; and others
National Institutes of Health (NIH)NHGRINotice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus$500,000 (direct costs)5/15/2020
Russell Sage Foundation Social, political, economic, or psychological disruptions that affect social and living conditions in the US$175,0005/21/2020 (LOI)
National Institutes of Health (NIH)NCATSNotice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)Check RFA(s) within6/5/2020 (other later deadlines within)
Solve at MITHealth Security and Pandemics Challenge $10,0006/18/2020
National Institutes of Health (NIH)NIAIDPartnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)$4,050,0006/29/2020
Amazon Web Services (AWS)AWS Diagnostic Development Initiative (DDI)Up to $20M available; budget should reflect your needs6/30/2020
National Institutes of Health (NIH)NIAIDCollaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)$275,000 (direct costs)9/9/2020
National Institutes of Health (NIH)NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIBEmergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)Not limitedSee Emergency Notice of Special Interest by IC
National Science Foundation (NSF)RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)$200,000Check with program officers
Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)$200,000 (RAPID) & supplemental funding requests

Last updated: 7/6/2021